Sign in

CIK 0001395937 · Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320162505
Phone
781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
  1. 424B5 Offering Prospectus
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. UPLOAD Other SEC-generated Letter
  4. S-3 Offering Registration Statement
  5. S-8 Other Securities Offered to Employees in Benefit Plans
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 8-K Event Executive or director change
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 8-K Event Shareholder vote results
  17. 4 Insider Changes in Ownership
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations
  20. DEF 14A Proxy Proxy Statement

Page 22 of 33 · 660 filings